CoChat

Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program

Open access
Perreault, Leigh, Kahn, Steven E., Christophi, Costas A., Knowler, William C., Hamman, Richard F., the Diabetes Prevention Program Research Group · 2009 · Diabetes Care

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Participants in the Diabetes Prevention Program (DPP) randomized to intensive lifestyle modification (ILS) or metformin had a significantly reduced incidence of diabetes compared with those randomized to placebo, yet most were still at risk because they had pre-diabetes. We explored the effect of baseline characteristics, weight change, ILS, and metformin on regression from pre-diabetes to the lowest-risk state of normal glucose regulation (NGR) defined by American Diabetes Association criteria. RESEARCH DESIGN AND METHODS: The DPP was a prospective randomized trial. Cox proportional hazards modeling was used to identify predictors of regression from pre-diabetes to NGR over 3 years of follow-up. RESULTS: Lower baseline fasting (hazard ratio 1.52, P < 0.01) and 2-h (1.24, P < 0.01) glucose predicted regression to NGR, as did younger age (1.07, P < 0.01) and greater insulin secretion (1.09, P = 0.04). ILS (2.05, P < 0.01) and weight loss (1.34, P < 0.01) had significant and independent effects on regression. A nonsignificant trend for regression was also observed for metformin (1.25, P = 0.06), male sex (1.17, P = 0.08), and insulin sensitivity (1.07, P = 0.09). In those entering the study with both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), male sex and insulin sensitivity predicted regression to isolated IFG, whereas ILS, metformin, female sex, and greater insulin secretion predicted regression to isolated IGT. CONCLUSIONS: Insulin secretion, and other biologic processes retained with younger age, are key in restoring NGR in people with pre-diabetes. However, NGR may also be attained through weight loss and additional aspects of ILS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-0523

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart for primary data analysis illustrating handling of the data from years 1 to 3. IFG, fasting glucose = 5.6–6.9 mmol/l; IGT, 2-h glucose = 7.8–11.1 mmol/l; NGR, fasting glucose <5.6 mmol/l; and 2-h glucose <7.8 mmol/l. Data “not included” were censored from subsequent analyses due to regression to NGR (in year prior), isolated IFG or IGT, progression to diabetes, or missing data.
Figure 1 Flowchart for primary data analysis illustrating handling of the data from years 1 to 3. IFG, fasting glucose = 5.6–6.9 mmol/l; IGT, 2-h glucose = 7.8–11.1 mmol/l; NGR, fasting glucose <5.6 mmol/l; and 2-h glucose <7.8 mmol/l. Data “not included” were censored from subsequent analyses due to regression to NGR (in year prior), isolated IFG or IGT, progression to diabetes, or missing data.CC BY-NC-ND · PubMed Central
Figure 2 Cumulative incidence of NGR according to treatment group, adjusted for baseline age, sex, ethnicity, weight, fasting and 2-h glucose concentrations, as well as insulin sensitivity (1/fasting insulin) and secretion (CIR).
Figure 2 Cumulative incidence of NGR according to treatment group, adjusted for baseline age, sex, ethnicity, weight, fasting and 2-h glucose concentrations, as well as insulin sensitivity (1/fasting insulin) and secretion (CIR).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

Items 101–200 of 209

Metadata

Authors
Perreault, L., Kahn, S. E., Christophi, C. A., Knowler, W. C., Hamman, R. F., & the Diabetes Prevention Program Research Group
Affiliations
  • University of Colorado Anschutz (US)
  • University of Washington (US)
  • George Washington University (US)
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • Colorado School of Public Health (US)
Venue
Diabetes Care
Published
2009-07-08
Volume
32
Issue
9
Pages
1583-1588
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2109748090
Cited by
209
References
25
Citations by year
2026: 8 · 2025: 15 · 2024: 19 · 2023: 12 · 2022: 9 · 2021: 16 · 2020: 14 · 2019: 12 · 2018: 15 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 14 · 2012: 9
FWCI
7.02
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
prediabetes, Diabetes Prevention Program, intensive lifestyle intervention, metformin, weight loss, insulin secretion, insulin sensitivity, impaired fasting glucose, impaired glucose tolerance
MeSH terms
Insulin Secretion, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Insulin, Life Style, Male, Metformin, Middle Aged, Prediabetic State, Sex Factors, Weight Loss, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.